HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of enterocutaneous fistula in a premature newborn by using octreotide.

Abstract
A premature newborn with an enterocutaneous fistula after repair of duodenal perforation is reported to emphasize the therapeutic effect of octreotide in persistent fistula even in a very small infant. Our report showed that use of octreotide was safe even in premature infants with intestinal fistula. Close monitorization of biochemical and blood parameters is needed in patients treated with octreotide.
AuthorsIlker Büyükyavuz, Ibrahim Karnak, Sule Yiğit, F Cahit Tanyel
JournalThe Turkish journal of pediatrics (Turk J Pediatr) 2004 Jul-Sep Vol. 46 Issue 3 Pg. 289-91 ISSN: 0041-4301 [Print] Turkey
PMID15503489 (Publication Type: Journal Article)
Chemical References
  • Gastrointestinal Agents
  • Octreotide
Topics
  • Gastrointestinal Agents (therapeutic use)
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases (drug therapy)
  • Intestinal Fistula (drug therapy)
  • Male
  • Octreotide (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: